483
BioChem Sioux City Inc.FDA 483 - BioChem Sioux City Inc. - March 19, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
BioChem Sioux City, Inc. in Sioux City, IA, was cited with two observations during an FDA inspection of its heparin sodium crude manufacturing operations. The firm failed to establish an ongoing stability program for heparin sodium crude to support its assigned expiration date. Additionally, the company has been using a modified heparin sodium assay method for 15-20 years without proper validation.
- Person
Open in Dashboard
ID · 4dcadc7f-060b-498f-a2cc-407a34ad2248